Shengfu Fan, Samuel D Calder, Nenagh Kemp, Alison Holm
{"title":"重铸治疗发展性语言障碍的最佳剂量特征:范围综述。","authors":"Shengfu Fan, Samuel D Calder, Nenagh Kemp, Alison Holm","doi":"10.1044/2025_JSLHR-24-00885","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this scoping review was to map and summarize currently available evidence about optimal dosage of recasting for developmental language disorder (DLD).</p><p><strong>Method: </strong>A systematic search of databases was completed, including Web of Science, Medline via OvidSP, PsycINFO, Cochrane Library, and Scopus. The inclusion criteria comprised the involvement of DLD intervention, the use of recasting alone or predominantly, and systematic manipulation of one or more dosage characteristics of recasting with the remaining parameters consistent across groups. Single-case experimental design studies were also included.</p><p><strong>Results: </strong>A total of 1,289 studies were included in the review, but only four articles met the criteria. Stratification analysis of an expanded set of 32 publications was then performed for effective dosage values, according to the way recasting was implemented. The effective quantitative dosage of recasting that has often been used is either an intervention duration > 8 weeks including a recast rate > 1.4/min within 30-min sessions, twice per week without high variability input, or a 5-week intervention including a recast rate of 0.8/min within 30-min sessions, five times per week with high variability input.</p><p><strong>Conclusions: </strong>Differences in the way dosage has been described and manipulated in the existing literature mean that the optimal dosage characteristics of recasting for DLD remain unknown. We propose ways to conceptualize dose and dose frequency to avoid ambiguities within the current framework of dosage. This review identifies ways that dosage characteristics of recasting for DLD can be manipulated and reported when designing interventions.</p><p><strong>Supplemental material: </strong>https://doi.org/10.23641/asha.30015529.</p>","PeriodicalId":520690,"journal":{"name":"Journal of speech, language, and hearing research : JSLHR","volume":" ","pages":"4917-4941"},"PeriodicalIF":2.2000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimal Dosage Characteristics of Recasting for Developmental Language Disorder: A Scoping Review.\",\"authors\":\"Shengfu Fan, Samuel D Calder, Nenagh Kemp, Alison Holm\",\"doi\":\"10.1044/2025_JSLHR-24-00885\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The purpose of this scoping review was to map and summarize currently available evidence about optimal dosage of recasting for developmental language disorder (DLD).</p><p><strong>Method: </strong>A systematic search of databases was completed, including Web of Science, Medline via OvidSP, PsycINFO, Cochrane Library, and Scopus. The inclusion criteria comprised the involvement of DLD intervention, the use of recasting alone or predominantly, and systematic manipulation of one or more dosage characteristics of recasting with the remaining parameters consistent across groups. Single-case experimental design studies were also included.</p><p><strong>Results: </strong>A total of 1,289 studies were included in the review, but only four articles met the criteria. Stratification analysis of an expanded set of 32 publications was then performed for effective dosage values, according to the way recasting was implemented. The effective quantitative dosage of recasting that has often been used is either an intervention duration > 8 weeks including a recast rate > 1.4/min within 30-min sessions, twice per week without high variability input, or a 5-week intervention including a recast rate of 0.8/min within 30-min sessions, five times per week with high variability input.</p><p><strong>Conclusions: </strong>Differences in the way dosage has been described and manipulated in the existing literature mean that the optimal dosage characteristics of recasting for DLD remain unknown. We propose ways to conceptualize dose and dose frequency to avoid ambiguities within the current framework of dosage. This review identifies ways that dosage characteristics of recasting for DLD can be manipulated and reported when designing interventions.</p><p><strong>Supplemental material: </strong>https://doi.org/10.23641/asha.30015529.</p>\",\"PeriodicalId\":520690,\"journal\":{\"name\":\"Journal of speech, language, and hearing research : JSLHR\",\"volume\":\" \",\"pages\":\"4917-4941\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of speech, language, and hearing research : JSLHR\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1044/2025_JSLHR-24-00885\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of speech, language, and hearing research : JSLHR","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1044/2025_JSLHR-24-00885","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:本综述的目的是绘制和总结目前可用的关于发育性语言障碍(DLD)的最佳剂量的证据。方法:系统检索Web of Science、Medline (OvidSP)、PsycINFO、Cochrane Library、Scopus等数据库。纳入标准包括DLD干预的介入,单独或主要使用重铸,以及系统地操纵重铸的一个或多个剂量特征,其余参数在组间保持一致。单例实验设计研究也包括在内。结果:共纳入1289项研究,但只有4篇文章符合标准。然后根据重铸的实施方式,对32份出版物的扩展集进行有效剂量值的分层分析。通常使用的重铸的有效定量剂量是干预持续时间bbbb8周,包括重铸率b>.4 /分钟,每次30分钟,每周两次,无高可变性输入;或干预5周,包括重铸率0.8/分钟,每次30分钟,每周5次,高可变性输入。结论:现有文献中剂量描述和操作方式的差异意味着DLD重铸的最佳剂量特征仍然未知。我们提出了将剂量和剂量频率概念化的方法,以避免在目前的剂量框架内产生歧义。本综述确定了在设计干预措施时可以操纵和报告DLD重铸的剂量特性的方法。补充资料:https://doi.org/10.23641/asha.30015529。
Optimal Dosage Characteristics of Recasting for Developmental Language Disorder: A Scoping Review.
Purpose: The purpose of this scoping review was to map and summarize currently available evidence about optimal dosage of recasting for developmental language disorder (DLD).
Method: A systematic search of databases was completed, including Web of Science, Medline via OvidSP, PsycINFO, Cochrane Library, and Scopus. The inclusion criteria comprised the involvement of DLD intervention, the use of recasting alone or predominantly, and systematic manipulation of one or more dosage characteristics of recasting with the remaining parameters consistent across groups. Single-case experimental design studies were also included.
Results: A total of 1,289 studies were included in the review, but only four articles met the criteria. Stratification analysis of an expanded set of 32 publications was then performed for effective dosage values, according to the way recasting was implemented. The effective quantitative dosage of recasting that has often been used is either an intervention duration > 8 weeks including a recast rate > 1.4/min within 30-min sessions, twice per week without high variability input, or a 5-week intervention including a recast rate of 0.8/min within 30-min sessions, five times per week with high variability input.
Conclusions: Differences in the way dosage has been described and manipulated in the existing literature mean that the optimal dosage characteristics of recasting for DLD remain unknown. We propose ways to conceptualize dose and dose frequency to avoid ambiguities within the current framework of dosage. This review identifies ways that dosage characteristics of recasting for DLD can be manipulated and reported when designing interventions.